Medicare Part D coverage · ethinyl estradiol · RxCUI 1736656
ethinyl estradiol 0.005 MG / norethindrone acetate 1 MG Oral Tablet [Fyavolv]
Per the CMS 2026 Part D formulary file, ethinyl estradiol 0.005 MG / norethindrone acetate 1 MG Oral Tablet [Fyavolv] is covered by 3,326 Medicare Part D plans (65.8% of enrollable products), averaging Tier 2.6, with prior authorization required on 3.8% of covering formularies.
- 65.8%
- Plan coverage
- 3,326
- Plans covering
- T2.6
- Avg tier
- 3.8%
- Prior auth required
What the CMS Formulary Data Shows for ethinyl estradiol 0.005 MG / norethindrone acetate 1 MG Oral Tablet [Fyavolv]
Per the CMS 2026 Part D formulary file, ethinyl estradiol 0.005 MG / norethindrone acetate 1 MG Oral Tablet [Fyavolv] (RxNorm concept RXCUI 1736656, generic name ethinyl estradiol) appears on 208 distinct formulary files spanning 3,326 Medicare Part D plan offerings - 65.8% of enrollable Part D products, mid-range placement; shopping across contracts changes access. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 2.6.
Real-world access to ethinyl estradiol 0.005 MG / norethindrone acetate 1 MG Oral Tablet [Fyavolv] depends on utilization management as much as tier placement: 3.8% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 3,693 Part D beneficiaries filled ethinyl estradiol 0.005 MG / norethindrone acetate 1 MG Oral Tablet [Fyavolv] in 2023, with total plan-and-beneficiary spending of $745,634 and an average per-beneficiary annual cost of $201.90. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry ethinyl estradiol 0.005 MG / norethindrone acetate 1 MG Oral Tablet [Fyavolv] today.
Coverage Details
- Formularies covering
- 208
- Plans covering
- 3,326
- Coverage rate
- 65.8%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 3.8% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 3,693
- Total spending
- $745,634
- Avg per beneficiary
- $201.90
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering ethinyl estradiol 0.005 MG / norethindrone acetate 1 MG Oral Tablet [Fyavolv]
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Sentara Community Complete Select (HMO D-SNP) | Sentara Health Plans | T1 | No | $0 | VA |
| Sentara Community Complete (HMO D-SNP) | Sentara Health Plans | T1 | No | $0 | VA |
| Florida Complete Care-Duals VIP (HMO-POS D-SNP) | Hpmp OF Florida, Inc. | T1 | No | $0 | FL |
| ElderServe MAP (HMO D-SNP) | Elderserve Health, Inc. | T1 | No | $0 | NY |
| Cooperative Advantage (HMO D-SNP) | Group Health Cooperative OF EAU Claire | T1 | No | $0 | WI |
| Longevity Health Plan (PPO I-SNP) | Longevity Health Plan OF NEW Jersey Insurance Comp | T1 | No | $0 | NJ |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | No | $0 | AZ |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | No | $0 | AZ |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | No | $0 | AZ |
| Elderplan Plus Long-Term Care (HMO-POS D-SNP) | Elderplan, Inc. | T1 | No | $0 | NY |
| Health Choice Pathway (HMO D-SNP) | Health Choice Arizona, Inc. | T1 | No | $0 | AZ |
| Healthfirst CompleteCare (HMO D-SNP) | Healthfirst Health Plan, Inc. | T1 | No | $0 | NY |
| IMCare Classic (HMO D-SNP) | Itasca Medical Care | T1 | No | $0 | MN |
| Johns Hopkins Advantage MD D-SNP (HMO D-SNP) | Hopkins Health Advantage, Inc. | T1 | No | $0 | MD |
| MetroPlus UltraCare (HMO D-SNP) | Metroplus Health Plan, Inc. | T1 | No | $0 | NY |
| Upper Peninsula Health Plan MI Coordinated Health (HMO D-SNP) | Upper Peninsula Health Plan, LLC | T1 | No | $0 | MI |
| CareSource Dual Advantage (HMO D-SNP) | Caresource Georgia Co. | T1 | No | $0 | GA |
| Senior Whole Health SCO (HMO D-SNP) | Senior Whole Health, LLC | T1 | No | $0 | MA |
| Senior Whole Health SCO NHC (HMO D-SNP) | Senior Whole Health, LLC | T1 | No | $0 | MA |
| Molina One Care (HMO D-SNP) | Senior Whole Health, LLC | T1 | No | $0 | MA |
Show the next 30 plans
| HAP CareSource MI Coordinated Health (HMO D-SNP) | HAP Caresource | T1 | No | $0 | MI |
| PruittHealth Premier D-SNP (HMO D-SNP) | Pruitthealth Premier, Inc. | T1 | No | $0 | GA |
| Simpra Advantage Dual Care (PPO D-SNP) | Simpra Advantage, Inc. | T1 | No | $0 | AL |
| CareAdvantage (HMO D-SNP) | SAN Mateo Health Commission | T1 | No | $0 | CA |
| NaviCare (HMO D-SNP) | Fallon Community Health Plan | T1 | No | $0 | MA |
| Hamaspik Medicare Choice (HMO D-SNP) | Hamaspik, Inc. | T1 | No | $0 | NY |
| SeniorCare Complete (HMO D-SNP) | South Country Health Alliance | T1 | No | $0 | MN |
| AbilityCare (HMO D-SNP) | South Country Health Alliance | T1 | No | $0 | MN |
| Alameda Alliance Wellness (HMO D-SNP) | Alameda Alliance FOR Health | T1 | No | $0 | CA |
| PHP (HMO C-snp) | Aids Healthcare Foundation | T1 | Yes | $0 | CA |
| CCA One Care (HMO D-SNP) | Commonwealth Care Alliance, Inc. | T1 | No | $0 | MA |
| CCA Senior Care Options (HMO D-SNP) | Commonwealth Care Alliance, Inc. | T1 | No | $0 | MA |
| VNS Health Total (HMO D-SNP) | VNS Choice | T1 | No | $0 | NY |
| Provider Partners Pennsylvania Community Plan (HMO I-SNP) | Provider Partners Health Plan OF Pennsylvania, Inc | T1 | No | $0 | PA |
| Provider Partners North Carolina Community Plan (HMO I-SNP) | Provider Partners Health Plan OF North Carolina | T1 | No | $0 | NC |
| Provider Partners Indiana Community Plan (HMO I-SNP) | Provider Partners Health Plan OF Indiana | T1 | No | $0 | IN |
| Provider Partners Missouri Community Plan (HMO I-SNP) | Provider Partners Health Plan OF Missouri, Inc. | T1 | No | $0 | MO |
| MMM Supremo (HMO C-SNP) | MMM Healthcare, LLC | T1 | No | $0 | PR |
| MMM Diamante Platino (HMO D-SNP) | MMM Healthcare, LLC | T1 | No | $0 | PR |
| MMM Unico (HMO-POS) | MMM Healthcare, LLC | T1 | No | $0 | PR |
| MMM Elite (HMO-POS) | MMM Healthcare, LLC | T1 | No | $0 | PR |
| MMM Deluxe (HMO-POS) | MMM Healthcare, LLC | T1 | No | $0 | PR |
| MMM Dorado Platino (HMO D-SNP) | MMM Healthcare, LLC | T1 | No | $0 | PR |
| PMC Premier Platino (HMO D-SNP) | MMM Healthcare, LLC | T1 | No | $0 | PR |
| PMC Max (HMO-POS) | MMM Healthcare, LLC | T1 | No | $0 | PR |
| MMM Plenitud (HMO-POS) | MMM Healthcare, LLC | T1 | No | $0 | PR |
| MMM Valioso (HMO-POS) | MMM Healthcare, LLC | T1 | No | $0 | PR |
| MMM Combo Platino (HMO D-SNP) | MMM Healthcare, LLC | T1 | No | $0 | PR |
| MMM Flexi Platino (HMO D-SNP) | MMM Healthcare, LLC | T1 | No | $0 | PR |
| MMM Grandioso (HMO-POS) | MMM Healthcare, LLC | T1 | No | $0 | PR |
Showing top 50 of 100 plans.
Frequently Asked Questions
Is ethinyl estradiol 0.005 MG / norethindrone acetate 1 MG Oral Tablet [Fyavolv] covered by Medicare Part D?
Yes, ethinyl estradiol 0.005 MG / norethindrone acetate 1 MG Oral Tablet [Fyavolv] is covered by 3,326 Medicare Part D plans (65.8% of all Part D formularies).
What tier is ethinyl estradiol 0.005 MG / norethindrone acetate 1 MG Oral Tablet [Fyavolv] on Medicare Part D plans?
ethinyl estradiol 0.005 MG / norethindrone acetate 1 MG Oral Tablet [Fyavolv] averages Tier 2.6 across Part D plans, ranging from Tier 1 to Tier 4.
Does ethinyl estradiol 0.005 MG / norethindrone acetate 1 MG Oral Tablet [Fyavolv] require prior authorization?
3.8% of Part D formularies require prior authorization for ethinyl estradiol 0.005 MG / norethindrone acetate 1 MG Oral Tablet [Fyavolv]. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on ethinyl estradiol 0.005 MG / norethindrone acetate 1 MG Oral Tablet [Fyavolv]?
In 2023, total Medicare Part D spending on ethinyl estradiol 0.005 MG / norethindrone acetate 1 MG Oral Tablet [Fyavolv] was $745,634, covering 3,693 beneficiaries. The average spend per beneficiary was $201.90.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
Similar prior-authorization rate
- 2 ML penicillin G benzathine 450000 UNT/ML / penicillin G procaine 150000 UNT/ML Prefilled Syringe [Bicillin] 3.8% PA
- {28 (ethinyl estradiol 0.005 MG / norethindrone acetate 1 MG Oral Tablet) } Pack 3.8% PA
- 1.5 ML aripiprazole 200 MG/ML Prefilled Syringe [Abilify] 3.7% PA
- 2 ML aripiprazole 200 MG/ML Prefilled Syringe [Abilify] 3.7% PA
- aripiprazole 400 MG Injection [Abilify] 3.7% PA
- prochlorperazine 10 MG Oral Tablet 3.7% PA